NEW YORK (GenomeWeb News) – BG Medicine said in a filing with the US Securities and Exchange Commission today that it has regained compliance with Nasdaq listing requirements.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.